Literature DB >> 17892523

Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease.

F Fornari1, K Blondeau, L Durand, E Rey, M Diaz-Rubio, A De Meyer, J Tack, D Sifrim.   

Abstract

BACKGROUND: Several studies showed high prevalence of ineffective oesophageal motility (IOM) in gastro-oesophageal reflux disease (GERD) and suggested an important role for ineffective oesophageal motility in increased acid exposure. However, impedance-manometric studies proposed that only severe ineffective oesophageal motility might affect oesophageal clearance.
OBJECTIVES: (i) To re-assess the relevance of mild IOM in GERD and (ii) to test the reversibility of IOM.
METHODS: Oesophageal motility, clearance and acid exposure were assessed in 191 GERD patients: 99 without IOM; 58 with mild IOM (30-80% ineffective contractions) and 34 with severe IOM (>80% ineffective contractions). In 30 patients with oesophagitis, the potential reversibility of IOM was evaluated with edrophonium intravenously.
RESULTS: Patients with mild IOM had identical oesophageal clearance and acid exposure in comparison with those without IOM. Patients with severe IOM had a higher probability of prolonged supine clearance and acid exposure [odds ratio: 2.88 (1.16-7.17); 2.48 (0.99-6.17)]. This effect was independent of the presence of hiatal hernia and male sex. Severe IOM could be transiently reverted in 55% of patients.
CONCLUSIONS: Mild IOM does not affect oesophageal clearance. Only severe IOM is associated with prolonged clearance and acid exposure, particularly in supine periods. The edrophonium test might be useful to predict severe IOM response to prokinetic medications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892523     DOI: 10.1111/j.1365-2036.2007.03525.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  18 in total

Review 1.  Therapeutic options in oesophageal dysphagia.

Authors:  Jan Tack; Giovanni Zaninotto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

Review 2.  Esophageal motility abnormalities in gastroesophageal reflux disease.

Authors:  Irene Martinucci; Nicola de Bortoli; Maria Giacchino; Giorgia Bodini; Elisa Marabotto; Santino Marchi; Vincenzo Savarino; Edoardo Savarino
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

Review 3.  Environmental - lifestyle related factors.

Authors:  Sabine Roman; John E Pandolfino
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-12       Impact factor: 3.043

4.  Gastroesophageal reflux disease is inversely related with glycemic control in morbidly obese patients.

Authors:  Adriana Lauffer; Cassiano Mateus Forcelini; Liana Ortiz Ruas; Carlos Augusto Scussel Madalosso; Fernando Fornari
Journal:  Obes Surg       Date:  2011-07       Impact factor: 4.129

5.  Long-term Outcomes of Patients With Normal or Minor Motor Function Abnormalities Detected by High-resolution Esophageal Manometry.

Authors:  Karthik Ravi; Laurel Friesen; Rachel Issaka; Peter J Kahrilas; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2015-03-11       Impact factor: 11.382

6.  Ineffective esophageal motility phenotypes following fundoplication in gastroesophageal reflux disease.

Authors:  M D Mello; A R Shriver; Y Li; A Patel; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2015-11-17       Impact factor: 3.598

7.  Rapid air infusion into the oesophagus: Motor response in patients with achalasia and nonobstructive dysphagia assessed with high-resolution manometry.

Authors:  Alessandra Elvevi; Aurelio Mauro; Dario Consonni; Delia Pugliese; Andrea Tenca; Marianna Franchina; Dario Conte; Roberto Penagini
Journal:  United European Gastroenterol J       Date:  2014-04       Impact factor: 4.623

8.  Nocturnal gastroesophageal reflux revisited by impedance-pH monitoring.

Authors:  Fernando Fornari; Kathleen Blondeau; Veerle Mertens; Jan Tack; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

Review 9.  Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium.

Authors:  C Prakash Gyawali; Daniel Sifrim; Dustin A Carlson; Mary Hawn; David A Katzka; John E Pandolfino; Roberto Penagini; Sabine Roman; Edoardo Savarino; Roger Tatum; Michel Vaezi; John O Clarke; George Triadafilopoulos
Journal:  Neurogastroenterol Motil       Date:  2019-04-11       Impact factor: 3.960

10.  High-resolution Manometry: Esophageal Disorders Not Addressed by the "Chicago Classification".

Authors:  Yu Tien Wang; Etsuro Yazaki; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.